Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Deutsche Bank downgrades AB Foods, Kingfisher and Wickes

(Sharecast News) - Deutsche Bank downgraded its stance on Associated British Foods, Kingfisher and Wickes on Tuesday as it took a look at the UK retail sector. "We are taking a more cautious view on the UK consumer," the bank said.

"The end of 2024 and early 2025 are likely to have been the sweet spot with real wage growth set to slow and fear of unemployment set to build from here. Our Household Cash Flow model shows discretionary spending lagging spending power and, unless consumers reduce savings, there will be a 4ppt slowdown in discretionary spend to +3% in 2H from +7% in 1H.

"Retail sales have been resilient into Q2 helped by warm weather although there is some variance by category."

DB said consumer confidence metrics remain subdued and its new "Fear Index" suggests things may be getting worse.

The bank cut Primark owner AB Foods and Wickes to 'sell' from 'hold', while Kingfisher was downgraded to 'hold' from 'buy'.

DB cut its price target on AB Foods to 2,130p from 2,220p, on Wickes to 195p from 205p and on Kingfisher to 280p from 320p.

Deutsche kept its rating on Dunelm at 'buy' and lifted the price target to 1,360p from 1,320p. Next was maintained at 'hold' but the price target upped to 11,600p from 10,800p, while Marks & Spencer was left at 'buy' and the price target cut to 435p from 450p.

Victorian Plumbing was kept at 'hold' and the price target nudged up to 70p from 95p.

At 0935 BST, AB Foods shares were down 4.1% at 2,220p, Kingfisher was 4.2% lower at 269.40p and Wickes was 8.5% weaker at 201.72p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.